Barberà Joan A, Escribano Pilar, Morales Pilar, Gómez Miguel A, Oribe Mikel, Martínez Angel, Román Antonio, Segovia Javier, Santos Francisco, Subirana María T
Servicio de Neumología, Hospital Clínic, Barcelona, España.
Rev Esp Cardiol. 2008 Feb;61(2):170-84.
Substantial progress in the diagnosis and treatment of patients with pulmonary hypertension in recent years has led to significant improvement in survival. Evidence-based clinical practice guidelines issued by scientific societies reflect these new developments. However, certain clinically relevant issues have not been covered in consensus guidelines because of the lack of conclusive scientific evidence. Therefore, the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Cardiology (SEC) have promoted the present consensus statement in order to define national standards of care in the evaluation and management of pulmonary hypertension in its various forms, as well as to outline a clinical pathway and the basic principles for organizing health care in this clinical setting, with special emphasis on the requirements for and functions of specialized referral units. To prepare the statement, SEPAR and SEC formed a task force composed of national experts in various aspects of pulmonary hypertension. The resulting consensus is based on international clinical guidelines, a review of available scientific evidence, and panel discussion among the task force members. The final statement, approved by all participants, underwent external review.
近年来，肺动脉高压患者的诊断和治疗取得了重大进展，生存率显著提高。科学协会发布的循证临床实践指南反映了这些新进展。然而，由于缺乏确凿的科学证据，某些临床相关问题尚未在共识指南中得到涵盖。因此，西班牙肺科和胸外科协会（SEPAR）和西班牙心脏病学会（SEC）推动了本共识声明的制定，以界定各种形式肺动脉高压评估和管理的国家护理标准，并概述在此临床环境中组织医疗保健的临床路径和基本原则，特别强调专科转诊单位的要求和功能。为编写该声明，SEPAR和SEC成立了一个由肺动脉高压各方面的国内专家组成的特别工作组。形成的共识基于国际临床指南、对现有科学证据的审查以及特别工作组成员之间的小组讨论。经所有参与者批准的最终声明进行了外部审查。
